Money Maker Medical Supply, Asset-Light Wholesale Distributor

$3.0M

Revenue

$511K

SDE

4.5x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a wholesale distributor of disposable medical supplies and over-the-counter healthcare products, deliberately built around roughly 17 large, high-value clients. The company avoids prescription (Rx) products entirely, which strips out most of the regulatory drag and compliance overhead that weighs on medical distribution, leaving a clean, straightforward operating model. It serves customers nationwide, sources inventory from established US wholesale distributors plus some Canadian supply, and runs everything through a third-party logistics provider so there is no owned warehouse, no employees, and virtually no FF&E.

The economics are the story here. On $3.02M of revenue the business throws off $510,637 in SDE, a 17 percent owner-earnings margin that is strong for distribution and reflects the deliberate strategy of chasing margin and cash flow over volume. Because a 3PL handles warehousing and fulfillment and the owner runs the whole thing solo, this is genuinely asset-light and location-independent, sold as relocatable and home-based out of Fort Lauderdale.

At a $2.3M ask against $510K SDE, the deal prices at roughly 4.5x, and it is lender pre-qualified with $500K down. The obvious tension is concentration: a business this profitable resting on 17 accounts is both the reason margins are high and the primary risk a buyer inherits. The upside pitch is that the vendor relationships and infrastructure are already in place, so a more aggressive operator could layer on new accounts without proportionally adding cost.

Why we like it

Earnings quality is genuinely strong: $510,637 SDE on $3.02M revenue is a 17 percent owner-earnings margin, well above typical distribution comps. With a 3PL handling fulfillment and no payroll, most of that margin converts to cash rather than getting eaten by working capital and overhead.
The moat is a curated book of roughly 17 high-value clients paired with established national and regional wholesale distributor relationships. Those vendor terms and pricing agreements are the real asset here, and they are what let a solo operator run a $3M top line profitably.
Disposable medical and OTC supplies are consumable, reorder-driven, and demand-inelastic, so revenue holds up through a downturn. Deliberately avoiding Rx products removes the heaviest layer of regulatory and licensing complexity while keeping the recession-resistant demand profile.
The operating model is exceptionally clean for a buyer: no warehouse, no employees, no meaningful FF&E, and only $5,000 of inventory. That means low fixed cost, easy relocation, and a lender pre-qualified structure requiring $500K down, which lowers the practical barrier to acquisition.

How to improve it

Attack customer concentration immediately by building a simple outbound pipeline. With only 17 accounts, even adding five to ten new mid-size clients using existing vendor pricing would materially de-risk the business and grow revenue without new infrastructure.
Formalize contracts and reorder terms with the top clients in the first 90 days. Convert informal purchasing relationships into standing supply agreements or auto-replenishment arrangements to protect against the single biggest risk in the deal, which is a large account walking.
Audit and renegotiate vendor pricing and rebate programs. Since gross margin drives the whole model, pushing for volume tiers, early-pay discounts, or private-label sourcing on the highest-turn SKUs directly expands the SDE that the purchase multiple was set against.
Layer a real sales and CRM function onto an operation that clearly has none. A part-time salesperson on commission plus a basic CRM would let the owner scale account count while keeping the asset-light structure intact.
Diversify the supply chain beyond the current US-plus-Canada mix to protect margins from tariff and freight volatility. Qualifying a second or third source on top SKUs also strengthens negotiating leverage on price.
Systematize the founder knowledge before the two-week transition ends. Document sourcing logic, pricing strategy, and client-specific quirks into SOPs so the business is transferable and not dependent on the sellers' undocumented relationships.

Diligence notes

Client concentration is the central issue: get revenue and gross margin broken out by each of the 17 accounts, plus tenure and reorder frequency. If the top two or three clients represent the majority of revenue, the effective multiple should be lower and the deal structured with an earnout or holdback.
Verify the $3,020,553 revenue and $510,637 SDE against tax returns and bank statements, and scrutinize the SDE add-backs since a no-employee, home-based business can have owner expenses commingled. Confirm the 17 percent margin is real and durable, not inflated by one strong year.
Diligence the vendor relationships and pricing terms directly, because they are the actual asset being purchased. Confirm they are transferable, not personal to the sellers, and check whether any key supplier terms depend on volumes tied to specific clients that could churn.
Examine the 3PL relationship: contract terms, pricing, capacity, switching costs, and whether the arrangement is assignable to a new owner. An asset-light model is only as stable as the logistics partner behind it, so understand what happens to margins if that provider raises rates.
Clarify how much of the business runs on the sellers' personal relationships and know-how, since two weeks of transition is thin for a relationship-driven distribution business. Push for a longer paid consulting period or a transition covering at least one full reorder cycle with each major client.

Source

Originally listed on BizBuySell. View original listing →